The ability of A2-derived HBV vaccines to protect against non-A2 HBV genotypes has recently been brought into question following the publication of a study of 3.7 million blood donors in the USA.

Engerix-B (hepatitis B vaccine [recombinant]) is a prescription vaccine that’s used to help prevent hepatitis B. Engerix-B comes as a liquid suspension for intramuscular injection. Engerix-B is ...

The Global Cancer Vaccines Market is experiencing a significant growth phase, with its valuation rising from $4,188 million in 2019 to an expected $7,303 million by 2027. This rep ...

Vaccination against HBV began 30 years ago with availability of plasma-derived, inactivated HBsAg vaccines. Soon after, recombinant HBsAg expressed in yeast cells led to the production of vaccines ...

Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient po ...

Korea GSK announced on the 10th that it has selected actress Lee Jung-hyun as the official model for its new advertising campaign for the only domestic meningococcal B vaccine 'Bexsero ...

The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable ...

These overlapping sites have been termed antiviral drug-associated potential vaccine escape mutants (ADAP-VEMs ... to be resolved include the significance of mixed genotype or recombinant HBV ...